APT Medical Inc.
688617
株式のランク
#3231
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
株価
$38.62
時価総額
$5.47B
変化（1日）
0.19%
変化（1年）
-17.07%
国
CN
取引 APT Medical Inc. (688617)
カテゴリー
Healthcare
APT Medical Inc.（688617）の収益
Jun 2026 時点の収益 TTM: $433.73M
APT Medical Inc. の最新の財務報告によると、現在の収益 (TTM) は $433.73M です。2024 年には $283.02M の収益があり、これは 2023 年の $233.13M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
APT Medical Inc. の収益履歴（2017 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $433.73M | 17.44% |
| 2025 | $369.32M | 30.49% |
| 2024 | $283.02M | 21.40% |
| 2023 | $233.13M | 32.24% |
| 2022 | $176.29M | 35.21% |
| 2021 | $130.38M | 77.65% |
| 2020 | $73.39M | 26.51% |
| 2019 | $58.01M | 65.05% |
| 2018 | $35.15M | 49.30% |
| 2017 | $23.54M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $48.23B | 11,019.58% |
US
|
|
| $37.54B | 8,555.60% |
IE
|
|
| $25.84B | 5,856.92% |
US
|
|
| $21.00B | 4,740.79% |
US
|
|
| $26.02B | 5,898.66% |
DE
|
